Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.
Annette Martin(Centre National de la Recherche Scientifique), Marc Girard(Centre National de la Recherche Scientifique), R Crainic(Centre National de la Recherche Scientifique), Czeslaw Wychowski(Centre National de la Recherche Scientifique), James M. Hogle(Harvard University), Thérèse Couderc(Inserm)
Cited by 133
Related Papers
A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
|PLoS Pathogens|2008|610
Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion
|PLoS Medicine|2008|511
Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study
|PLoS neglected tropical diseases|2013|494
Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.
|Proceedings of the National Academy of Sciences|1983|377
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells
|The Journal of Experimental Medicine|2010|314